×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for Amneal Pharmaceuticals, Inc. (AMRX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AMRXAmneal Pharmaceuticals, Inc.Konidaris TasosExecutive Vice President & CFOMar 12, 2024Option Exercise$5.3130,790163,495527,316Mar 14, 2024, 04:17 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMar 01, 2024Option Exercise$5.4716,21988,718274,998Mar 05, 2024, 04:40 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMar 03, 2024Option Exercise$5.4744,562243,754319,381Mar 05, 2024, 04:40 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentFeb 27, 2024Option Exercise$5.7116,55694,535259,846Feb 29, 2024, 04:26 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentFeb 27, 2024Option Exercise$5.7118,670106,606336,922Feb 29, 2024, 04:25 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentAug 11, 2023Sale$4.1329,302120,921244,739Aug 15, 2023, 04:30 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentJun 30, 2023Option Exercise$3.1011,57135,870274,041Jul 05, 2023, 04:30 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMar 03, 2023Option Exercise$1.9218,06434,683319,972Mar 07, 2023, 06:00 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMar 03, 2023Option Exercise$1.9219,68537,795262,517Mar 07, 2023, 06:00 PM
AMRXAmneal Pharmaceuticals, Inc.Daly Jason B.SVP, Chief Legal OfficerMar 03, 2023Option Exercise$1.928,16415,67514,481Mar 07, 2023, 06:00 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMar 01, 2023Option Exercise$2.0922,05946,103301,804Mar 03, 2023, 04:31 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentFeb 27, 2023Option Exercise$2.1617,55737,923222,201Mar 01, 2023, 04:30 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentFeb 27, 2023Option Exercise$2.1619,75242,664283,176Mar 01, 2023, 04:30 PM
AMRXAmneal Pharmaceuticals, Inc.COULTER JAMES GFormer 10% OwnerDec 12, 2022Sale$2.343,884,6009,095,40212,328,767Dec 14, 2022, 05:01 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentJun 30, 2022Option Exercise$3.1811,58236,831208,096Jul 05, 2022, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentMay 07, 2022Option Exercise$3.401,5625,311327,194May 10, 2022, 06:58 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMay 07, 2022Option Exercise$3.402,2287,575267,308May 10, 2022, 06:57 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMay 07, 2022Option Exercise$3.408,35328,400196,584May 10, 2022, 06:41 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentMar 01, 2022Option Exercise$4.4513,23758,905324,314Mar 03, 2022, 09:22 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMar 01, 2022Option Exercise$4.4512,51255,678265,094Mar 03, 2022, 09:21 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMar 01, 2022Option Exercise$4.4521,92597,566188,281Mar 03, 2022, 09:17 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentFeb 27, 2022Option Exercise$4.5911,10750,981299,896Mar 01, 2022, 05:12 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentFeb 27, 2022Option Exercise$4.5911,69553,680236,921Mar 01, 2022, 05:11 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentFeb 27, 2022Option Exercise$4.5916,43475,432166,490Mar 01, 2022, 05:08 PM
AMRXAmneal Pharmaceuticals, Inc.Patel GautamDirectorDec 17, 2021Buy$4.2150,000210,500258,784Dec 20, 2021, 06:49 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President & Co-CEODec 16, 2021Buy$4.2550,000212,500512,566Dec 17, 2021, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President & Co-CEODec 15, 2021Buy$4.13100,000413,000462,566Dec 17, 2021, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEODec 15, 2021Buy$4.13100,000413,000462,566Dec 17, 2021, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEODec 16, 2021Buy$4.2550,000212,500512,566Dec 17, 2021, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentDec 15, 2021Sale$3.952,0007,900212,996Dec 17, 2021, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentDec 02, 2021Sale$4.101,5006,150281,319Dec 03, 2021, 06:19 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentJun 30, 2021Option Exercise$5.1211,58359,305151,262Jul 01, 2021, 04:03 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentMay 07, 2021Option Exercise$5.201,5628,122282,819May 11, 2021, 02:56 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMay 07, 2021Option Exercise$5.201,3667,103214,996May 11, 2021, 02:55 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentMar 15, 2021Sale$4.7972,660347,773316,270Mar 17, 2021, 04:05 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMar 15, 2021Sale$4.8172,660349,397248,251Mar 17, 2021, 04:04 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentMar 01, 2021Option Exercise$5.186,19232,075131,448Mar 02, 2021, 04:36 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExecutive Vice PresidentFeb 27, 2021Option Exercise$5.3916,30187,862125,294Mar 02, 2021, 04:36 PM
AMRXAmneal Pharmaceuticals, Inc.Manzano StephenSVP, General CounselFeb 27, 2021Option Exercise$5.395,79631,24010,694Mar 02, 2021, 12:00 AM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentFeb 27, 2021Option Exercise$5.3911,54862,244203,799Mar 02, 2021, 12:00 AM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaExecutive Vice PresidentMar 01, 2021Option Exercise$5.183,60718,684211,921Mar 02, 2021, 12:00 AM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentFeb 27, 2021Option Exercise$5.3910,97259,139272,735Mar 02, 2021, 12:00 AM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephExecutive Vice PresidentMar 01, 2021Option Exercise$5.183,90620,233279,940Mar 02, 2021, 12:00 AM
AMRXAmneal Pharmaceuticals, Inc.Kiely JohnDirectorMay 19, 2020Buy$4.4010,00044,00010,000May 19, 2020, 11:46 AM
AMRXAmneal Pharmaceuticals, Inc.George Jeffrey P.DirectorMay 15, 2020Buy$4.1623,81099,05023,810May 15, 2020, 04:15 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExec VP, Comm OptnsMay 07, 2020Option Exercise$3.558,35329,653109,933May 08, 2020, 07:28 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaSVP, Chief HR OfficerMay 07, 2020Option Exercise$3.551,3264,707179,727May 08, 2020, 07:12 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephSVP, Specialty CommercialMay 07, 2020Option Exercise$3.552,2127,853254,024May 08, 2020, 07:11 PM
AMRXAmneal Pharmaceuticals, Inc.MEISTER PAUL MDirectorMar 17, 2020Buy$2.79149,439416,935149,439Mar 19, 2020, 05:48 PM
AMRXAmneal Pharmaceuticals, Inc.MEISTER PAUL MDirectorMar 18, 2020Buy$2.71204,210553,409353,649Mar 19, 2020, 05:48 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEO and DirectorMar 10, 2020Buy$3.09100,000309,000356,107Mar 11, 2020, 07:54 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President, Co-CEO & DirectorMar 10, 2020Buy$3.09100,000309,000356,107Mar 11, 2020, 07:54 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President, Co-CEO & DirectorMar 02, 2020Buy$3.8734,641134,06140,748Mar 10, 2020, 09:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President, Co-CEO & DirectorMar 03, 2020Buy$3.88156,421606,913197,169Mar 10, 2020, 09:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel Chirag K.President, Co-CEO & DirectorMar 04, 2020Buy$3.9758,938233,984256,107Mar 10, 2020, 09:15 PM
AMRXAmneal Pharmaceuticals, Inc.Patel GautamDirectorMar 02, 2020Buy$3.8832,111124,59138,218Mar 10, 2020, 09:14 PM
AMRXAmneal Pharmaceuticals, Inc.Patel GautamDirectorMar 03, 2020Buy$3.94117,889464,483156,107Mar 10, 2020, 09:14 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEO and DirectorMar 04, 2020Buy$3.9758,765233,297256,107Mar 10, 2020, 09:13 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEO and DirectorMar 02, 2020Buy$3.8734,696134,27440,803Mar 10, 2020, 09:13 PM
AMRXAmneal Pharmaceuticals, Inc.Patel ChintuCo-CEO and DirectorMar 03, 2020Buy$3.88156,539607,371197,342Mar 10, 2020, 09:13 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaSVP, Chief HR OfficerMar 01, 2020Option Exercise$3.854,22816,278176,611Mar 03, 2020, 07:27 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExec VP, Comm OptnsMar 01, 2020Option Exercise$3.856,68325,730101,630Mar 03, 2020, 07:27 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephSVP, Specialty CommercialMar 01, 2020Option Exercise$3.856,16223,724251,794Mar 03, 2020, 07:26 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephSVP, Specialty CommercialFeb 28, 2020Buy$3.6240,000144,800246,845Mar 03, 2020, 07:26 PM
AMRXAmneal Pharmaceuticals, Inc.Branning Todd P.SVP and CFOJan 22, 2020Option Exercise$5.137,31137,50512,785Jan 23, 2020, 05:42 PM
AMRXAmneal Pharmaceuticals, Inc.BUCHEN DAVID ASVP, Chief Legal OfficerJan 03, 2020Option Exercise$4.728,18838,64720,426Jan 06, 2020, 05:20 PM
AMRXAmneal Pharmaceuticals, Inc.Nark Ted CDirectorAug 28, 2019Buy$2.3950,000119,50056,107Aug 28, 2019, 04:53 PM
AMRXAmneal Pharmaceuticals, Inc.Bhadauria PradeepSVP, Chief Scientific OfficerAug 16, 2019Buy$2.4130,00072,30037,500Aug 19, 2019, 09:03 PM
AMRXAmneal Pharmaceuticals, Inc.Fosun International Ltd10% OwnerAug 06, 2019Buy$2.91327,000951,570327,000Aug 08, 2019, 06:15 AM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExec VP, Comm OptnsAug 07, 2019Buy$2.8966,666192,66595,968Aug 07, 2019, 04:32 PM
AMRXAmneal Pharmaceuticals, Inc.Fosun International Ltd10% OwnerAug 05, 2019Buy$3.041,642,3004,992,5921,642,300Aug 07, 2019, 08:58 AM
AMRXAmneal Pharmaceuticals, Inc.Bhadauria PradeepSVP, Chief Scientific OfficerMay 15, 2019Buy$8.487,00059,3607,500May 16, 2019, 04:59 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExec VP, Comm OptnsMay 13, 2019Buy$9.4619,000179,74029,302May 13, 2019, 05:27 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephSVP, Specialty CommercialMay 13, 2019Buy$9.8815,000148,200205,590May 13, 2019, 05:27 PM
AMRXAmneal Pharmaceuticals, Inc.Todisco JosephSVP, Specialty CommercialMay 07, 2019Option Exercise$13.442,22829,944190,590May 09, 2019, 05:45 PM
AMRXAmneal Pharmaceuticals, Inc.BOYER ANDREW SExec VP, Comm OptnsMay 07, 2019Option Exercise$13.448,353112,26410,302May 09, 2019, 05:44 PM
AMRXAmneal Pharmaceuticals, Inc.BISARO PAULExecutive ChairmanMay 07, 2019Option Exercise$13.4412,529168,39029,454May 09, 2019, 05:43 PM
AMRXAmneal Pharmaceuticals, Inc.Stewart Robert APresident and CEOMay 07, 2019Option Exercise$13.4421,609290,42578,668May 09, 2019, 05:43 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaSVP, Chief HR OfficerMay 07, 2019Option Exercise$13.441,36618,359169,111May 09, 2019, 05:42 PM
AMRXAmneal Pharmaceuticals, Inc.Stewart Robert APresident and CEOMar 12, 2019Buy$11.9217,000202,64017,000Mar 12, 2019, 04:49 PM
AMRXAmneal Pharmaceuticals, Inc.BISARO PAULExecutive ChairmanMar 12, 2019Buy$11.9717,000203,49017,000Mar 12, 2019, 04:45 PM
AMRXAmneal Pharmaceuticals, Inc.TERRERI PETER RDirectorMar 06, 2019Option Exercise$8.5468,345583,99570,192Mar 07, 2019, 05:41 PM
AMRXAmneal Pharmaceuticals, Inc.BURR ROBERT LDirectorJan 15, 2019Option Exercise$6.5530,000196,50090,475Jan 16, 2019, 05:16 PM
AMRXAmneal Pharmaceuticals, Inc.Shah NikitaSVP, Chief HR OfficerAug 21, 2018Sale$23.4650,0001,173,000166,036Aug 23, 2018, 04:51 PM
AMRXAmneal Pharmaceuticals, Inc.Reasons Bryan M.CFOAug 21, 2018Sale$23.6511,698276,65882,986Aug 23, 2018, 04:50 PM
AMRXAmneal Pharmaceuticals, Inc.APHC Holdings, LLC10% OwnerMay 04, 2018Sale$18.2546,849,316855,000,0176,886,140May 08, 2018, 07:28 PM